TipRanks
Go Ultimate55% OFF

Circassia Pharmaceuticals (CSSPF) Balance Sheet

Circassia Pharmaceuticals Balance Sheet

Circassia Pharmaceuticals's total assets for Q2 2026 were $73.10M, a decrease of 4.07% from the previous quarter. CSSPF total liabilities were $7.00M for the fiscal quarter, a 18.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 76.20M$ 68.40M$ 91.50M$ 98.50M$ 86.40M
$ 8.60M$ 8.90M$ 7.70M$ 16.60M$ 19.60M
$ 67.60M$ 59.50M$ 83.80M$ 81.90M$ 66.80M

Currency in GBP

Circassia Pharmaceuticals Debt to Assets

0150M300M450M0 %25 %50 %75 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets